skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Survival of women with breast cancer in central and northern Denmark, 1998–2009

Original Research

(1173) Views  (255) Full article downloads

Authors: Lietzen LW, Sørensen GV, Ording AG, Garne JP, Christiansen P, Nørgaard M, Jacobsen J

Published Date July 2011 Volume 2011:3(Supplement 1) Pages 35 - 40
DOI: http://dx.doi.org/10.2147/CLEP.S20627

Lone Winther Lietzen1, Gitte Vrelits Sørensen1, Anne Gulbech Ording1, Jens Peter Garne2, Peer Christiansen3, Mette Nørgaard1, Jacob Jacobsen1
1Department of Clinical Epidemiology, 2Department of Breast Surgery, Aalborg Hospital, 3Breast and Endocrine Section, Department of Surgery P, Aarhus University Hospital, Denmark

Objective: Breast cancer is the most common cancer among women worldwide. The Nordic countries have relatively high survival, but Denmark has a lower survival than neighboring countries. A breast cancer screening program was introduced in 2007 and 2008 in the northern and central regions of Denmark respectively. We aimed to examine possible changes in survival of Danish breast cancer patients in central and northern Denmark in the period 1998–2009.
Materials and methods: From the northern and central Denmark regions, we included all women (n = 13,756) with an incident diagnosis of breast cancer, as recorded in the Danish National Registry of Patients during the period January 1, 1998 through December 31, 2009. We calculated age-stratified survival and used Cox proportional hazard regression to estimate mortality rate ratios (MRRs) for all breast cancer patients.
Results: Median age was 62 years (21–102 years). The overall 1-year survival improved steadily over the period from 90.9% in 1998–2000 to 94.4% in 2007–2009, corresponding to a 1-year age adjusted MRR of 0.68 in 2007–2009 compared with the reference period 1998–2000. We estimated the 5-year survival to improve from 70.0% in 1998–2000 to 74.7% in 2007–2009, corresponding to a 5-year age adjusted MRR of 0.82 in 2007–2009 compared with the reference period 1998–2000. For middle-aged women (50–74 years) 1-year survival increased from 92.8% in 1998–2000 to 96.6% in 2008–2009, and 5-year survival was expected to increase from 73.9% in 1998–2000 to 80.2% in 2007–2009. Among younger women (15–49 years) and elderly women (>75 years), 1-year survival and 5-year predicted survival did not change over the two time periods.
Conclusion: Survival of breast cancer patients has improved in Denmark over the period 1998–2009, and this change was most distinct in women aged 50–74 years. Survival improved even before the implementation of a formal breast cancer screening program.

Keywords: breast neoplasm, mortality, epidemiology, population-based








Readers of this article also read:

The catastrophic collapse of morale among hospital physicians in Japan
Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors
Specifying exposure classification parameters for sensitivity analysis: family breast cancer history
Existing data sources for clinical epidemiology: Aarhus University Prescription Database
Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark
Appraising relative and excess mortality in population-based studies of chronic diseases such as end-stage renal disease
Multiple treatment comparison meta-analyses: a step forward into complexity
Survival in patients with synchronous liver metastases in central and northern Denmark, 1998 to 2009
Survival of prostate cancer patients in central and northern Denmark, 1998–2009
Characteristics of Dutch and Swiss primary care COPD patients - baseline data of the ICE COLD ERIC study